Category: Boston ScientificSyndicate content

Boston Scientific launches trial for Acuity X4, Reliance 4-Front leads

April 23, 2014 by Brad Perriello

Boston Scientific launches a clinical trial for its Acuity X4 pacemaker and Reliance 4-Front defibrillator leads, ahead of its bid for U.S. FDA approval of the devices.

keys: boston scientific, bsx, acuity x4, reliance 4-front

Boston Scientific lands FDA approval for next-gen heart devices

April 16, 2014 by Arezu Sarvestani

Boston Scientific gets the FDA's OK for a new generation of defibrillators and heart failure devices, including some of the world's smallest and thinnest ICDs.

Boston Scientific lands FDA approval for next-gen heart devices

Boston Scientific (NYSE:BSX) announced this week that it won FDA approval for its newest suite of cardiac devices, including next-generation defibrillators and heart failure devices.

Appeals court vacates ban on Boston Scientific's Guidezilla catheter

April 15, 2014 by Brad Perriello

A federal appeals court vacates a lower court's decision to keep Boston Scientific's Guidezilla catheter off the U.S. market in the patent infringement lawsuit brought by Vascular Solutions.

Appeals court vacates ban on Boston Scientific's Guidezilla catheter

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Plaintiffs look to remove pelvic mesh cases to Pennsylvania state court

April 14, 2014 by Brad Perriello

Plaintiffs in product liability lawsuits against several makes of pelvic mesh products, including Boston Scientific, Johnson & Johnson and Secant Medical, want a federal judge to send the cases back to a Pennsylvania state court.

Plaintiffs look to remove pelvic mesh cases to Pennsylvania state court

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Boston Scientific launches Parkinson's brain stim registry

April 14, 2014 by Arezu Sarvestani

Medtech titan Boston Scientific enrolls the first patient in a clinical registry evaluating the Vercise deep brain stimulation system for Parkinson's disease.

Boston Scientific launches Parkinson's brain stim study

Boston Scientific (NYSE:BSX) kicked off a new registry evaluating deep brain stimulation in treatment of Parkinson's disease.

Boston Scientific makes new friends in Israel

April 9, 2014 by Arezu Sarvestani

Medtech titan Boston Scientific plans to sell a slew of its products in Israel through a partnership with distributor Amos Gazit Ltd and marketing group Medison.

Boston Scientifics makes new friends in Israel

Massachusetts medical device maker Boston Scientific (NYSE:BSX) has a new partner in Israel, agreeing to supply a slate of its products through local distributor Amos Gazit Ltd

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp